TW200732337A - Organic compounds - Google Patents

Organic compounds

Info

Publication number: TW200732337A
Authority: TW; Taiwan
Prior art keywords: organic compounds; pharmaceuticals; preparing; formula; free
Prior art date: 2005-12-09

Application number

TW095146173A

Other languages

English (en)

Inventor

David Andrew Sandham

Catherine Leblanc

Harinder Pal Singh

Lyndon Nigel Brown

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-09

Filing date

2006-12-08

Publication date

2007-09-01

2006-12-08 Application filed by Novartis Ag filed Critical Novartis Ag

2007-09-01 Publication of TW200732337A publication Critical patent/TW200732337A/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

TW095146173A 2005-12-09 2006-12-08 Organic compounds TW200732337A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0525144.2A GB0525144D0 (en)	2005-12-09	2005-12-09	Organic compounds

Publications (1)

Publication Number	Publication Date
TW200732337A true TW200732337A (en)	2007-09-01

Family

ID=35735863

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095146173A TW200732337A (en)	2005-12-09	2006-12-08	Organic compounds

Country Status (17)

Country	Link
US (1)	US20080312229A1 (zh)
EP (1)	EP1960398B1 (zh)
JP (1)	JP2009518343A (zh)
KR (1)	KR20080065699A (zh)
CN (1)	CN101326185A (zh)
AR (1)	AR056887A1 (zh)
AT (1)	ATE482957T1 (zh)
AU (1)	AU2006322206B2 (zh)
BR (1)	BRPI0619529A2 (zh)
CA (1)	CA2630611A1 (zh)
DE (1)	DE602006017256D1 (zh)
GB (1)	GB0525144D0 (zh)
PE (1)	PE20071035A1 (zh)
PT (1)	PT1960398E (zh)
RU (1)	RU2008127439A (zh)
TW (1)	TW200732337A (zh)
WO (1)	WO2007065683A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY144903A (en) *	2004-06-17	2011-11-30	Novartis Ag	Pyrrolopyridine derivatives and their use as crth2 antagonists
GB0525143D0 (en) *	2005-12-09	2006-01-18	Novartis Ag	Organic compounds
SI2051962T1 (sl)	2006-08-07	2012-02-29	Actelion Pharmaceuticals Ltd	Derivati (3-amino-1,2,3,4-tetrahidro-9h-karbazol-9-il)-ocetne kisline
US8563573B2 (en)	2007-11-02	2013-10-22	Vertex Pharmaceuticals Incorporated	Azaindole derivatives as CFTR modulators
WO2009093029A1 (en) *	2008-01-22	2009-07-30	Oxagen Limited	Compounds having crth2 antagonist activity
CN108383789A (zh) *	2010-01-27	2018-08-10	艾克提麦斯医药品有限公司	作为crth2拮抗剂的吡唑化合物
DK2558447T3 (da)	2010-03-22	2014-11-10	Actelion Pharmaceuticals Ltd	3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazolderivater og deres anvendelse som prostaglandin d2-receptormodulatorer
US8802868B2 (en)	2010-03-25	2014-08-12	Vertex Pharmaceuticals Incorporated	Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
MX2012012204A (es)	2010-04-22	2012-12-05	Vertex Pharma	Proceso para producir compuestos de cicloalquilcarboxamido-indol.
EP2457900A1 (en)	2010-11-25	2012-05-30	Almirall, S.A.	New pyrazole derivatives having CRTh2 antagonistic behaviour
MY165623A (en)	2011-04-14	2018-04-18	Idorsia Pharmaceuticals Ltd	7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
MX350516B (es) *	2011-11-17	2017-09-08	Kbp Biosciences Co Ltd	Compuestos de anillo fusionado que contienen nitrogeno como antagonistas crth2.
LT3119779T (lt)	2014-03-17	2018-09-10	Idorsia Pharmaceuticals Ltd	Azaindolo acto rūgšties dariniai ir jų panaudojimas kaip prostaglandino d2 receptoriaus moduliatorių
MX2016011900A (es)	2014-03-18	2016-12-05	Actelion Pharmaceuticals Ltd	Derivados de acido azaindol-acetico y su uso como moduladores del receptor de prostaglandina d2.
DK3925607T3 (da)	2014-04-15	2023-08-21	Vertex Pharma	Farmaceutiske sammensætninger til behandlingen af cystisk fibrosetransmembrankonduktansregulator-medierede sygdomme
CA2993893A1 (en)	2015-09-15	2017-03-23	Idorsia Pharmaceuticals Ltd	Crystalline forms
KR20200104291A (ko)	2017-11-06	2020-09-03	랩트 테라퓨틱스, 인크.	항암제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3320268A (en) *	1964-08-14	1967-05-16	Merck & Co Inc	1-aroyl or heteroaroyl-7-azaindole-3-carboxylates and derivatives
HUE026285T2 (en) *	2003-02-06	2016-05-30	Dompe Farm Spa	2-arylacetic acid compounds and their derivatives and pharmaceutical compositions containing them
MY144903A (en) *	2004-06-17	2011-11-30	Novartis Ag	Pyrrolopyridine derivatives and their use as crth2 antagonists

2005
- 2005-12-09 GB GBGB0525144.2A patent/GB0525144D0/en not_active Ceased
2006
- 2006-12-06 PE PE2006001570A patent/PE20071035A1/es not_active Application Discontinuation
- 2006-12-07 RU RU2008127439/04A patent/RU2008127439A/ru unknown
- 2006-12-07 AU AU2006322206A patent/AU2006322206B2/en not_active Ceased
- 2006-12-07 CN CNA2006800462767A patent/CN101326185A/zh active Pending
- 2006-12-07 US US12/096,453 patent/US20080312229A1/en not_active Abandoned
- 2006-12-07 PT PT06819000T patent/PT1960398E/pt unknown
- 2006-12-07 KR KR1020087013721A patent/KR20080065699A/ko not_active Abandoned
- 2006-12-07 CA CA002630611A patent/CA2630611A1/en not_active Abandoned
- 2006-12-07 BR BRPI0619529-6A patent/BRPI0619529A2/pt not_active IP Right Cessation
- 2006-12-07 DE DE602006017256T patent/DE602006017256D1/de active Active
- 2006-12-07 AT AT06819000T patent/ATE482957T1/de not_active IP Right Cessation
- 2006-12-07 AR ARP060105412A patent/AR056887A1/es unknown
- 2006-12-07 JP JP2008543732A patent/JP2009518343A/ja active Pending
- 2006-12-07 WO PCT/EP2006/011770 patent/WO2007065683A1/en not_active Ceased
- 2006-12-07 EP EP06819000A patent/EP1960398B1/en not_active Not-in-force
- 2006-12-08 TW TW095146173A patent/TW200732337A/zh unknown

Also Published As

Publication number	Publication date
ATE482957T1 (de)	2010-10-15
CN101326185A (zh)	2008-12-17
RU2008127439A (ru)	2010-01-20
CA2630611A1 (en)	2007-06-14
WO2007065683A1 (en)	2007-06-14
EP1960398A1 (en)	2008-08-27
AU2006322206A1 (en)	2007-06-14
US20080312229A1 (en)	2008-12-18
AU2006322206B2 (en)	2010-08-19
PE20071035A1 (es)	2007-10-30
KR20080065699A (ko)	2008-07-14
BRPI0619529A2 (pt)	2011-10-04
JP2009518343A (ja)	2009-05-07
PT1960398E (pt)	2010-11-26
EP1960398B1 (en)	2010-09-29
AR056887A1 (es)	2007-10-31
GB0525144D0 (en)	2006-01-18
DE602006017256D1 (de)	2010-11-11

Publication	Publication Date	Title
TW200732335A (en)	2007-09-01	Organic compounds
TW200617009A (en)	2006-06-01	Organic compounds
TW200635921A (en)	2006-10-16	Organic compounds
SG169989A1 (en)	2011-04-29	Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
TW200800999A (en)	2008-01-01	Novel compounds
TW200732337A (en)	2007-09-01	Organic compounds
TW200745084A (en)	2007-12-16	Novel compounds
MX2009007713A (es)	2009-07-29	Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
TW200505920A (en)	2005-02-16	Organic compounds
TW200800967A (en)	2008-01-01	Benzimidazole thiophene compounds
DE602004024213D1 (en)	2009-12-31	Aminopropanolderivate
SE0401762D0 (sv)	2004-07-05	Novel compounds
TW200637837A (en)	2006-11-01	Fungicides
GB0412769D0 (en)	2004-07-07	Organic compounds
GB0508318D0 (en)	2005-06-01	Organic compounds
TW200508197A (en)	2005-03-01	Indolone-acetamide derivatives, processes for preparing them and their uses
ES2368594T3 (es)	2011-11-18	Derivados sustituidos de ciclohexilmetilo.
JO2734B1 (en)	2013-09-15	Organic compounds
TW200638930A (en)	2006-11-16	Acetylene derivatives
MXPA05013823A (es)	2006-02-28	Derivados de pirrolidinio y piperidino como ligandos para el receptor m3 muscarinico.
MY140739A (en)	2010-01-15	2, 6-quinolinyl derivatives, processes for preparing them and their uses
GB0411929D0 (en)	2004-06-30	Organic compounds
BRPI0519292A2 (pt)	2009-01-06	compostos orgÂnicos
GB0508314D0 (en)	2005-06-01	Organic compounds
WO2007065684A3 (en)	2007-08-02	Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents